BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  H3 Biomedicine Announces First Patient Dosed With H3B-6545 In Phase I Study In Breast Cancer

  September 5, 2017

   · 

  4 min read
• Biotech Beach

  Biocept Launches Liquid Biopsy Test For NRAS Mutations

  September 5, 2017

   · 

  5 min read
• Drug Development

  ReViral Initiates Phase IIa Study Of RV521 For Treatment Of Respiratory Syncytial Virus

  September 5, 2017

   · 

  4 min read
• 1st Patient Recruited In Orthocell Ortho-ATI Shoulder Tendon Study

  September 5, 2017

   · 

  2 min read
• Business

  ApiFix Signs Distribution Agreement In Canada; Completes First Cases In North America At IWK Health Centre Hospital, Halifax

  September 5, 2017

   · 

  2 min read
• Business

  Co-Diagnostics To Sign Purchase Agreement With MEDCIS Pathlabs

  September 5, 2017

   · 

  2 min read
• Drug Development

  Eagle Pharma Announces Positive Results Of Study Conducted To Evaluate Neuroprotective Effects Of RYANODEX Secondary To Nerve Agent Exposure

  September 5, 2017

   · 

  6 min read
• Drug Development

  Citius Pharma Provides Phase III Update On Mino-Lok Clinical Trial Following FDA Meeting

  September 5, 2017

   · 

  4 min read
• Drug Development

  ProQR Therapeutics’s Drug Candidate QRX-421 For Usher Syndrome Receives Orphan Drug Designation From FDA And EMA

  September 5, 2017

   · 

  5 min read
• Drug Development

  Biocryst Announces Positive Results From Its Apex-1 Phase II Trial In HAE

  September 5, 2017

   · 

  9 min read